MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$2,417,984
EPS
-$0.58
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
Total revenue
-0* 0
General and administrative
1,612,267 1,413,606* 1,443,827
Research and development
2,123,725 2,590,724* 2,729,891
Collaboration credits
1,233,224 2,091,493* 1,658,248
In-process r&d impairment
-4,624,000* 0
Change in fair value of contingent consideration
7,427 3,910,925* -1,721,033
Total operating expenses
2,510,195 10,447,762* 794,437
Operating loss
-2,510,195 -10,447,762* -794,437
Impairment of intangible assets
-0* -
Loss on disposal of fixed assets
-0* -
Interest income
-273,566* -
Interest expense
-4,990* -
Interest income, net
139,338 -201,822
Other expense, net
-47,127 -89,148* -23,708
Total other income, net
92,212 179,428* 178,114
Loss before income tax provision
-2,417,984 -10,268,334* -616,323
Income tax provision
0 647,238* -643,129
Net loss
-2,417,984 -10,915,572 26,806
Net loss attributable to common shareholders
-2,417,984 -26,806
Net loss attributable to common shareholders
-2,417,984 -10,915,572 26,806
Basic EPS
-0.58 -2.7 0.01
Diluted EPS
-0.58 -2.838 0.01
Basic Average Shares
4,174,802 4,043,531 4,289,853
Diluted Average Shares
4,174,802 3,846,006 4,361,740
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$2,417,984 Net lossattributable to common...-$2,417,984 Net loss-$2,417,984 Interest income, net$139,338 Loss before incometax provision-$2,417,984 Total other income,net$92,212 Other expense, net-$47,127 Operating loss-$2,510,195 Total operatingexpenses$2,510,195 Research and development$2,123,725 General andadministrative$1,612,267

KIORA PHARMACEUTICALS INC (KPRX)

KIORA PHARMACEUTICALS INC (KPRX)